About Bionovo (OTCMKTS:BNVIQ)
Bionovo, Inc. is a drug discovery and development company, which focuses on women's health and development of drugs for the treatment of cancer. The Company's drug candidates include Menerba, Seala, Bezielle, BN107 and BN108. Its Menerba is a selective estrogen receptor beta agonist, which reduces the frequency and severity of menopausal hot flashes. The Company has completed a randomized, double-blind, placebo-controlled Phase II clinical trial of Menerba. Bezielle is an orally delivered anti-cancer agent. The Company is engaged in an open label, multi-center Phase I/II trial of Bezielle for the treatment of advanced metastatic breast cancer. The Company's Seala is a selective estrogen receptor beta agonist, which acts as an intra-vaginal suppository. The Company's anti-cancer agents include BN107 and BN108, which are used for the treatment of advanced breast cancer. BN107 and BN108 are in pre-clinical development stage.
Industry, Sector and Symbol
Trailing P/E Ratio-0.00088235294117647
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-417.31%
Return on Assets-204.78%
Bionovo (OTCMKTS:BNVIQ) Frequently Asked Questions
What is Bionovo's stock symbol?
Bionovo trades on the OTCMKTS under the ticker symbol "BNVIQ."
Who are some of Bionovo's key competitors?
Some companies that are related to Bionovo include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), AbbVie (ABBV), Merck & Co., Inc. (MRK), Amgen (AMGN), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Abbott Laboratories (ABT), GlaxoSmithKline (GSK), Thermo Fisher Scientific (TMO), AstraZeneca (AZN), Sanofi (SAN), Bayer (BAYN), Celgene (CELG) and CSL (CSL).
How do I buy Bionovo stock?
Shares of Bionovo can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Bionovo?
Bionovo's mailing address is 5858 Horton St Ste 400, EMERYVILLE, CA 94608-2046, United States. The healthcare company can be reached via phone at +1-510-6012000.
MarketBeat Community Rating for Bionovo (BNVIQ)MarketBeat's community ratings are surveys of what our community members think about Bionovo and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Bionovo (OTCMKTS:BNVIQ) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Bionovo (OTCMKTS:BNVIQ) Earnings History and Estimates Chart
Bionovo (OTCMKTS BNVIQ) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Bionovo (OTCMKTS:BNVIQ) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Bionovo (OTCMKTS:BNVIQ)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Bionovo (OTCMKTS BNVIQ)
No insider trades for this company have been tracked by MarketBeat.com
Bionovo (OTCMKTS BNVIQ) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Bionovo (OTCMKTS:BNVIQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Bionovo (OTCMKTS BNVIQ) Stock Chart for Saturday, February, 24, 2018